Orion Infusions (DHA:ORIONINFU) FCF Yield % : 0.34 (As of May. 28, 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Orion Infusions's Trailing 12-Month Free Cash Flow is BDT38.9 Mil, and Market Cap is BDT11,509.4 Mil. Therefore, Orion Infusions's FCF Yield % for today is 0.34%.

The historical rank and industry rank for Orion Infusions's FCF Yield % or its related term are showing as below:

DHA:ORIONINFU' s FCF Yield % Range Over the Past 10 Years
Min: -16.5 Med: 1.3 Max: 32.61
Current: 0.34

During the past 13 years, the highest FCF Yield % of Orion Infusions was 32.61%. The lowest was -16.50%. And the median was 1.30%.

DHA:ORIONINFU's FCF Yield % is ranked better than
54.44% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.335 vs DHA:ORIONINFU: 0.34

Orion Infusions's FCF Margin % for the quarter that ended in Mar. 2024 was 26.82%.

Orion Infusions FCF Yield % Historical Data

The historical data trend for Orion Infusions's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions FCF Yield % Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

4.66

3.11

0.46

1.46

-0.11

Orion Infusions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															0.22	-0.91	0.05	-0.13	2.14

Competitive Comparison of Orion Infusions's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Infusions's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Orion Infusions's FCF Yield % falls into.

Orion Infusions FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Orion Infusions's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-7.255	/	6851.0727
	=	-0.11%

Orion Infusions's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	56.026	*	4	/	10493.44092
	=	2.14%

Orion Infusions FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Orion Infusions FCF Yield % Related Terms

Thank you for viewing the detailed overview of Orion Infusions's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines